apremilast

Apremilast Therapeutic Cheat Sheet
apremilast
by Alexis Carrington, MD on
Apremilast (OTEZLA®) is a twice daily oral medication that is FDA approved for adults with plaque psoriasis, psoriatic arthritis and oral ulcers associated with Behçet’s Disease.1 This drug is being extended as an off-label treatment to target inflammation in a number of different conditions. This Therapeutic Cheat Sheet will focus on apremilast and its applications for different dermatologica …
Translating Psoriasis Guidelines into Practice
psoriasis guidelines
by Mojgan Hosseinipour, DO, FAAD on
Before we dive into our discussion, let’s outline the Guideline-Based Approach to Treatment Selection. The International Psoriasis Council has divided psoriasis treatment classification into 2 groups: Patients who are a candidate for topical therapy, or Patients who are a candidate for systemic therapy Candidates for systemic therapy must meet at least 1 of the following …
Successful Use of Tildrakizumab for Treatment of Palmoplantar Pustulosis
Palmoplantar Pustulosis
by NEXT STEPS IN DERM TEAM on
Palmoplantar pustulosis (PPP) is a rare, recurrent skin disorder that presents a major challenge to clinical therapy. JDD author Danilo C. Del Campo, MD, FAAD reports a case of a 69-year-old woman with a 20-year history of psoriasis with skin manifestations and clinical and pathologic features consistent with PPP. After intolerance to apremilast and unsuccessful use of topical corticosteroids and …
The Art of Nail Findings in Patients with Skin of Color
nail findings
by Jacqueline McKesey, MD, MS on
Dr. Shari Lipner, Associate Professor of Clinical Dermatology and Director of the Nail Division at Weill Cornell Medicine and President of The Dermatologic Society of Greater New York, shared her expertise of nail disorders in patients with skin of color: from nail psoriasis and onychomycosis to subungual melanoma. Dr. Lipner’s lecture focused on the following key points (spoiler alert!): …
August 2021 JDD Issue | Special Focus on Psoriasis
PSORIASIS
by NEXT STEPS IN DERM TEAM on
With a special focus on psoriasis, the August issue of the Journal of Drugs in Dermatology features an outstanding editorial line-up with articles, features, and case reports on topics ranging from antihistamines in psoriasis, facial erythema in rosacea, management of AKs, to herpes zoster following COVID-19 vaccination, cutaneous angiosarcoma of the scalp, and everything in between! Straight fr …